Fox Chase Cancer Center News

PHILADELPHIA (July 23, 2021) – Although it improved certain aspects of adaptive coping among prostate cancer survivors, a small randomized, controlled trial found use of PROGRESS, a web-based intervention developed at Fox Chase Cancer Center, did not fully address coping and psychosocial demands. 

PHILADELPHIA (July 23, 2021)—Fox Chase Cancer Center recently awarded grants to two fellows to continue work on projects related to patient care in their fields. These funds were raised as part of Fox Chase’s annual In Vino Vita Benefit and Wine Auction.

PHILADELPHIA (July 22, 2021)—In a study published today in JAMA Oncology, researchers at Fox Chase Cancer Center found that the odds of a patient undergoing prostate cancer surgery were lower among Black patients compared with white patients during the initial wave of the COVID-19 pandemic.

PHILADELPHIA (July 22, 2021)—Charline Ogier, PhD, a postdoctoral researcher at Fox Chase Cancer Center, was recently awarded a fellowship from the Pancreatic Cancer Action Network (PanCAN) to continue her work in advancing pancreatic cancer therapies.

PHILADELPHIA (July 22, 2021)—Ralph Francescone, PhD, a researcher at Fox Chase Cancer Center, was recently awarded a grant from the Pancreatic Cancer Action Network (PanCAN) to continue his work in advancing pancreatic cancer therapies.

PHILADELPHIA (July 20, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Zachary Frosch, MD, MSHP, who will join the Department of Hematology/Oncology as an assistant professor.

PHILADELPHIA (July 20, 2021)—Delinda Pendleton, BSN, MSN, a long-time employee at Fox Chase Cancer Center, has been named a Planetree Fellow in Person-Centered Care. The fellows program is operated by Planetree International, a leading person-centered care advocacy and standard setting organization.

PHILADELPHIA (July 13, 2021)—Researchers at Fox Chase Cancer Center have recently shown that sonic hedgehog-driven (SHH) medulloblastoma relapse may be prevented by targeting the transdifferentiation—a cell’s ability to convert from one type of cell to another—of astrocytes.